UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Hepatology international, 2016-01, Vol.10 (1), p.1-98

2016

Volltextzugriff (PDF)

Anti‐viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post‐partum flare

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1225-1234

2014

Volltextzugriff (PDF)

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

Gut, 2011-02, Vol.60 (2), p.247-254

2011

Volltextzugriff (PDF)

More than a virus: a qualitative study of the social implications of hepatitis B infection in China

International journal for equity in health, 2017-08, Vol.16 (1), p.137-137, Article 137

2017

Volltextzugriff (PDF)

Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression

Virology (New York, N.Y.), 2020-01, Vol.540, p.97-103

2020

Volltextzugriff (PDF)

Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations

Journal of viral hepatitis, 2014-11, Vol.21 (11), p.809-817

2014

Volltextzugriff (PDF)

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen

Journal of virology, 2014-09, Vol.88 (18), p.10412-10420

2014

Volltextzugriff (PDF)

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

Antimicrobial Agents and Chemotherapy, 2004-09, Vol.48 (9), p.3498-3507

2004

Volltextzugriff (PDF)

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging

Antiviral research, 2007-11, Vol.76 (2), p.168-177

2007

Volltextzugriff (PDF)

Hepatitis B virus mutations associated with antiviral therapy

Journal of medical virology, 2006, Vol.78 (S1), p.S52-S55

2006

Volltextzugriff (PDF)

Molecular virology of hepatitis B virus, sub-genotype C4 in northern Australian Indigenous populations

Journal of medical virology, 2014-04, Vol.86 (4), p.695-706

2014

Volltextzugriff (PDF)

A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation

Journal of viral hepatitis, 2014-12, Vol.21 (12), p.905-908

2014

Volltextzugriff (PDF)

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.114-122

2018

Volltextzugriff (PDF)

International coalition to eliminate hepatitis B - progress report

Journal of hepatology, 2017, Vol.66 (1), p.S698-S698

2017

Volltextzugriff (PDF)

Whole-genome deep sequencing of hepatitis B virus in chronic hepatitis B patients reveals single nucleotide variants associated with baseline HBV DNA levels and HBeAg status

Journal of hepatology, 2017, Vol.66 (1), p.S679-S679

2017

Volltextzugriff (PDF)

On-treatment ALT flares are associated with HBsAg loss in genotype A chronic hepatitis B-infected patients treated with nucleotide analogue therapy

Journal of hepatology, 2017, Vol.66 (1), p.S260-S260

2017

Volltextzugriff (PDF)

P0652 : Effect of tenofovir on key hepatitis B virus markers in pregnant women during the third trimester and postpartum

Journal of hepatology, 2015-04, Vol.62, p.S565-S565

2015

Volltextzugriff (PDF)

Durability of HBsAg loss with nucleotide analogs and pegylated interferon in patients infected with hepatitis B virus

Journal of hepatology, 2017, Vol.66 (1), p.S264-S264

2017

Volltextzugriff (PDF)

A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population

Journal of hepatology, 2017, Vol.66 (1), p.S265-S265

2017

Volltextzugriff (PDF)

Characterization of the innate immune signalling pathways in hepatocyte cell lines

Journal of viral hepatitis, 2008-12, Vol.15 (12), p.888-900

2008

Volltextzugriff (PDF)

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

Hepatology (Baltimore, Md.), 1998-06, Vol.27 (6), p.1730-1735

1998

Volltextzugriff (PDF)

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients

Journal of viral hepatitis, 2016-03, Vol.23 (3), p.170-179

2016

Volltextzugriff (PDF)

Controlling viral hepatitis: Public policy lessons from Taiwan

Journal of clinical virology, 2015-08, Vol.69, p.240-241

2015

Volltextzugriff (PDF)

On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHB

Journal of hepatology, 2017, Vol.66 (1), p.S259-S260

2017

Volltextzugriff (PDF)

The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes

Journal of viral hepatitis, 2011-10, Vol.18 (10), p.e499-e507

2011

Volltextzugriff (PDF)

1 – 25 von 763

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(640)
Mit Volltextzugriff
(675)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(123)
Hepatology
(55)
Antiviral Therapy
(26)
Gastroenterology
(24)
Medical Journal Of Australia
(22)
Journal Of Gastroenterology And Hepatology
(21)
Journal Of Viral Hepatitis
(20)
Journal Of Medical Virology
(19)
Journal Of Virology
(17)
Journal Of Clinical Virology
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Anti‐viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post‐partum flare

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

More than a virus: a qualitative study of the social implications of hepatitis B infection in China

Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression

Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging

Hepatitis B virus mutations associated with antiviral therapy

Molecular virology of hepatitis B virus, sub-genotype C4 in northern Australian Indigenous populations

A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients

International coalition to eliminate hepatitis B - progress report

Whole-genome deep sequencing of hepatitis B virus in chronic hepatitis B patients reveals single nucleotide variants associated with baseline HBV DNA levels and HBeAg status

On-treatment ALT flares are associated with HBsAg loss in genotype A chronic hepatitis B-infected patients treated with nucleotide analogue therapy

P0652 : Effect of tenofovir on key hepatitis B virus markers in pregnant women during the third trimester and postpartum

Durability of HBsAg loss with nucleotide analogs and pegylated interferon in patients infected with hepatitis B virus

A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population

Characterization of the innate immune signalling pathways in hepatocyte cell lines

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients

Controlling viral hepatitis: Public policy lessons from Taiwan

On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHB

The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes

Suchergebnisse filtern